Immune Repertoire Sequencing Market, By Product (Assay Kits and Software & Services), By Application, By Technology, By End User, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV1278
|
Published Date
April 2026
|
Pages
413
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Immune Repertoire Sequencing Market size was valued at US$ 360.55 Million in 2025, expanding at a CAGR of 9.57% from 2026 to 2033.
Immune Repertoire Sequencing (IRS) is an advanced laboratory technique used to study how the human immune system responds to diseases by analyzing genetic patterns of B-cells and T-cells. Using high-throughput DNA sequencing technologies, it examines B-cell and T-cell receptors, which act as recognition molecules for detecting infections and abnormal cells. This provides valuable insights into conditions such as cancer, infectious diseases, and autoimmune disorders. In simple terms, IRS can be viewed as mapping the immune system’s “memory” to understand how immune responses evolve over time.
From a broader perspective, the adoption of IRS is supported by public health initiatives and sustained research funding. Institutions such as the National Institutes of Health (NIH) provide significant financial support for genomics and immunology research, enabling large-scale scientific studies in this field. Similarly, guidance from the U.S. Food and Drug Administration (FDA) helps ensure the proper validation and clinical application of sequencing-based technologies. Overall, strong public investment in biomedical research—supported by NIH funding reaching tens of billions of dollars annually—continues to drive the development and adoption of advanced technologies such as immune repertoire sequencing in healthcare and research systems.
Immune Repertoire Sequencing Market- Market Dynamics
Increasing Adoption of Precision Medicine and Genomic Healthcare Integration
The growing shift toward precision medicine is supporting the adoption of immune repertoire sequencing in both clinical and research settings. Governments are actively promoting genomic-based healthcare systems to improve disease detection and enhance treatment accuracy. For instance, China’s Ministry of Science and Technology supports national precision medicine programs that integrate genomic sequencing into cancer and immune-related research. In Japan, the Ministry of Health, Labour and Welfare is advancing genomic medicine initiatives aimed at incorporating sequencing into routine clinical decision-making. Similarly, the European Medicines Agency provides regulatory guidance to ensure the safe and effective use of sequencing-based diagnostic tools in healthcare applications. On the industry side, companies are continuously advancing sequencing technologies to align with the needs of precision healthcare. F. Hoffmann-La Roche Ltd has expanded its molecular diagnostics portfolio to enable improved disease profiling and support targeted therapies. Likewise, Thermo Fisher Scientific has developed enhanced sequencing platforms that strengthen immune cell analysis and advance research in personalized medicine.
Immune Repertoire Sequencing Market- Segmentation Analysis:
The Global Immune Repertoire Sequencing Market is segmented on the basis of Product, Application, Technology, End User, and Region.
Considering different product categories, software and services continue to be widely adopted in the market, as laboratories increasingly rely on digital tools to interpret complex immune data rather than focusing only on raw sequencing outputs. These solutions support the organization, analysis, and visualization of large-scale immune receptor information in a more efficient and practical manner. From a commercial perspective, 10x Genomics has expanded its cloud-based analysis tools for single-cell immune profiling workflows, enabling researchers to process sequencing data with greater clarity and efficiency. Similarly, QIAGEN has strengthened its bioinformatics software platforms designed for immune sequencing interpretation and data management.
Next-generation sequencing (NGS) continues to hold strong relevance in the market from a technology standpoint, primarily due to its ability to generate high-throughput and detailed genetic information from immune cells. It is widely preferred in research environments where large-scale immune profiling is required, as it enables deeper analysis of B-cell and T-cell receptor diversity. From a commercial perspective, Illumina has developed advanced NGS platforms widely used in immunogenomics workflows for accurate sequencing output. Likewise, BGI Genomics applies NGS-based systems in large-scale biological research projects to support immune system studies, while Pacific Biosciences contributes long-read sequencing technologies that enhance resolution of complex immune receptor regions.
Immune Repertoire Sequencing Market- Geographical Insights
A geographical analysis of the immune repertoire sequencing market shows that growth is strongly influenced by investments in genomic research, healthcare infrastructure, and precision medicine initiatives. Among regions, Asia-Pacific is expected to register significant growth, supported by expanding biotechnology ecosystems and increasing government focus on advanced genomics. For instance, policy direction from China’s Ministry of Industry and Information Technology (MIIT) promotes the advancement of biomedical research and the adoption of advanced sequencing technologies in laboratories, supporting large-scale immune profiling studies. Similarly, India’s government-backed genomic and life sciences initiatives encourage collaboration between research institutions and industry, strengthening sequencing capabilities and clinical applications. From an industry perspective, BGI Genomics in China provides high-throughput sequencing services for immune profiling and population-scale studies, while Takara Bio in Japan advances immune profiling technologies, including T-cell receptor (TCR) and B-cell receptor (BCR) sequencing tools for oncology and translational research.
In addition to Asia-Pacific, North America remains a key region in the market due to strong institutional research activity and sustained public investment in genomics. The region benefits from supportive regulatory frameworks that encourage innovation in precision medicine and immunology research. For example, the National Institutes of Health (NIH) supports large-scale genomic initiatives such as the All of Us Research Program, which has generated nearly 100,000 whole genome sequences to advance disease research and precision medicine. Similarly, programs under the National Institute of Allergy and Infectious Diseases (NIAID) support sequencing-based clinical research initiatives, integrating genomics into healthcare and patient care applications.
Australia Immune Repertoire Sequencing Market- Country Insights
In Australia, immune repertoire sequencing is gradually being integrated into both research and healthcare applications, supported by strong academic institutions and a well-structured public health system. The country places significant emphasis on medical research, particularly in areas such as cancer, infectious diseases, and immune-related disorders, where a deeper understanding of the immune system is essential. The Australian Government has committed AUD 500 million under the Genomics Health Futures Mission to strengthen genomic research and its clinical applications, including immune-based studies. Similarly, national initiatives such as the RNA Blueprint, along with programs like the AUD 15 billion National Reconstruction Fund and the AUD 1.6 billion Australia’s Economic Accelerator, aim to enhance biotechnology capabilities and support the development of advanced therapeutics.
From an industry perspective, companies such as Illumina, Inc. provide sequencing platforms widely used in immune profiling research, while Thermo Fisher Scientific supports laboratories with reagents and analytical solutions for complex immune system studies.
Immune Repertoire Sequencing Market- Competitive Landscape:
Amid growing awareness in genomics and precision medicine, the immune repertoire sequencing field is shaped by the presence of both established life science companies and specialized technology providers, creating a dynamic and evolving market landscape. Companies such as Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN, and 10x Genomics offer solutions through direct sales, digital platforms, and research collaborations. They focus on key parameters such as data accuracy, workflow efficiency, technological advancement, and service support to strengthen their market position. Ongoing efforts including product innovation, expansion of sequencing capabilities, and partnerships with research institutions are commonly observed across the industry. For instance, Thermo Fisher Scientific has introduced enhanced immune sequencing assays to improve analytical sensitivity, while QIAGEN has expanded its bioinformatics capabilities through strategic acquisitions to support integrated data analysis. Similarly, 10x Genomics has advanced its single-cell sequencing platforms to enable deeper immune system insights.
Recent Developments:
- In February 2026, Illumina announced an expansion of its immunogenomics workflow solutions through improved library preparation kits designed for deeper immune profiling. This development reflects a continued shift toward more reliable and standardized immune sequencing workflows, supporting consistent research outcomes and broader scientific adoption.
- In November 2025, Adaptive Biotechnologies entered a collaboration with Genentech to analyze immune receptor data for advancing cell therapy research. This partnership aims to support deeper immune system insights and contribute to the development of next-generation cell therapies and improved approaches to complex disease research.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Illumina
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd
- QIAGEN
- BGI Genomics
- 10x Genomics
- Oxford Nanopore Technologies
- Pacific Biosciences
- Agilent Technologies
- ArcherDX
- Adaptive Biotechnologies
- iRepertoire
- Creative Biolabs
- New England Biolabs
- Danaher Corporation
- Azenta Life Sciences
- Celemics
- Singleron Biotechnologies
- Eurofins Scientific
- Novogene
- BD (Becton Dickinson)
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Assay Kits
- BCR Kits
- TCR Kits
- Software & Services
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinical Diagnostics
- Drug Discovery & Development
- Research Applications
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Next-Generation Sequencing (NGS)
- PCR-Based Sequencing
- Single-Cell Sequencing
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Labs
- Pharma & Biotech Companies
- Academic and Research Institutes
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Immune Repertoire Sequencing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Immune Repertoire Sequencing Market Snippet by Product
2.1.2. Immune Repertoire Sequencing Market Snippet by Application
2.1.3. Immune Repertoire Sequencing Market Snippet by Technology
2.1.4. Immune Repertoire Sequencing Market Snippet by End User
2.1.5. Immune Repertoire Sequencing Market Snippet by Country
2.1.6. Immune Repertoire Sequencing Market Snippet by Region
2.2. Competitive Insights
3. Immune Repertoire Sequencing Key Market Trends
3.1. Immune Repertoire Sequencing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immune Repertoire Sequencing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immune Repertoire Sequencing Market Opportunities
3.4. Immune Repertoire Sequencing Market Future Trends
4. Immune Repertoire Sequencing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immune Repertoire Sequencing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Immune Repertoire Sequencing Market Landscape
6.1. Immune Repertoire Sequencing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immune Repertoire Sequencing Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
7.1.2. Assay Kits
7.1.2.1. BCR Kits
7.1.2.2. TCR Kits
7.1.3. Software & Services
7.1.4. Others
8. Immune Repertoire Sequencing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Clinical Diagnostics
8.1.3. Drug Discovery & Development
8.1.4. Research Applications
8.1.5. Others
9. Immune Repertoire Sequencing Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
9.1.2. NGS
9.1.3. PCR-Based Sequencing
9.1.4. Single-Cell Sequencing
9.1.5. Others
10. Immune Repertoire Sequencing Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. Diagnostic Labs
10.1.3. Pharma & Biotech Companies
10.1.4. Academic and Research Institutes
10.1.5. Others
11. Immune Repertoire Sequencing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Immune Repertoire Sequencing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Immune Repertoire Sequencing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Immune Repertoire Sequencing Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Immune Repertoire Sequencing Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Immune Repertoire Sequencing Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Immune Repertoire Sequencing Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Illumina
12.2.2. Thermo Fisher Scientific
12.2.3. F. Hoffmann-La Roche Ltd
12.2.4. QIAGEN
12.2.5. BGI Genomics
12.2.6. 10x Genomics
12.2.7. Oxford Nanopore Technologies
12.2.8. Pacific Biosciences
12.2.9. Agilent Technologies
12.2.10. ArcherDX
12.2.11. Adaptive Biotechnologies
12.2.12. iRepertoire
12.2.13. Creative Biolabs
12.2.14. New England Biolabs
12.2.15. Danaher Corporation
12.2.16. Azenta Life Sciences
12.2.17. Celemics
12.2.18. Singleron Biotechnologies
12.2.19. Eurofins Scientific
12.2.20. Novogene
12.2.21. BD (Becton Dickinson)
12.2.22. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Illumina
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd
- QIAGEN
- BGI Genomics
- 10x Genomics
- Oxford Nanopore Technologies
- Pacific Biosciences
- Agilent Technologies
- ArcherDX
- Adaptive Biotechnologies
- iRepertoire
- Creative Biolabs
- New England Biolabs
- Danaher Corporation
- Azenta Life Sciences
- Celemics
- Singleron Biotechnologies
- Eurofins Scientific
- Novogene
- BD (Becton Dickinson)
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Assay Kits
- BCR Kits
- TCR Kits
- Software & Services
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinical Diagnostics
- Drug Discovery & Development
- Research Applications
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Next-Generation Sequencing (NGS)
- PCR-Based Sequencing
- Single-Cell Sequencing
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Labs
- Pharma & Biotech Companies
- Academic and Research Institutes
- Others
GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
